Targeted agents in acute myeloid leukemia in elderly patients
Results of trial of vadastuximab talirine plus hypomethylating agents in AML
The progress in treating Hodgkin lymphoma
How far are we from a cure for CLL?
Mechanism of action of venetoclax (ABT-199) and its side effects